Skip to content

Efficacy of a Unani Formulation in the Management of Diabetes Mellitus

A Clinical Study to Evaluate the Efficacy and Safety of a Unani Formulation in the Management of Ziabetus Shakari (Diabetes Mellitus): A Randomized, Active Controlled, Parallel Group Clinical Trial - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077199
Enrollment
60
Registered
2024-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Unani Polyherbal Formulation: Unani Polyherbal Formulation Dosage Form: Safuf (Powder) Dose: 6gm Frequency: Twice a Day half hour before meals Route of Administration: Orally Duration:

Sponsors

Dr Saba Khan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients age group 18 to 60 years old of any gender. Fasting Plasma Glucose levels between 126mg/dl and 150 mg/dl or Postparandial Plasma Glucose levels ranging from 200 mg/dl to 250 mg/dl 2 hour after ingestion of 75mg of glucose in 300ml of water or HbA1C levels ranging 6.5% to 10%. Presence of symptoms and signs of diabetes mellitus type2.

Exclusion criteria

Exclusion criteria: Patients having any deliberating systemic disease. Patients on insulin therapy and suffering from diabetes mellitus type-1. Patients with complications of Diabetes mellitus type2 Patients suffering from thyroid function disorders. Pregnant and lactating women. Known case of immunocompromised states (HIC, AIDS etc) or malignancies.

Design outcomes

Primary

MeasureTime frame
1 Fasting and PP glucose level 2 HBA1c level 3 Improvement in symptoms and signs on VAS Scale (0-10)Timepoint: Baseline 2 Weeks 4 Weeks 6 Weeks 8 Weeks

Secondary

MeasureTime frame
1 Haemogram 2 Lft 3 Kft 4 Lipid Profile 5 Urine RMTimepoint: Baseline 2 Weeks 4 Weeks 6 Weeks 8 Weeks

Countries

India

Contacts

Public ContactDr Abdul Qadir

State Takmeel ut Tib College and Hospital Lucknow

aq.ayaz5775@gmail.com9415757169

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026